Dynamical modeling of drug effect using hybrid systems.

about

Integrating Multiscale Modeling with Drug Effects for Cancer Treatment Time-Based Switching Control of Genetic Regulatory Networks: Toward Sequential Drug Intake for Cancer Therapy.

P2860

Q26770510-01EBF448-A03A-4786-8081-52F357C8F13A Q33685652-6AA1DDB3-612A-4571-AEC4-1F4927F999FF

P2860

Dynamical modeling of drug effect using hybrid systems.

Item

http://www.wikidata.org/entity/Q36803684

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Dynamical modeling of drug effect using hybrid systems.

@ast

Dynamical modeling of drug effect using hybrid systems.

@en

type

Item

label

Dynamical modeling of drug effect using hybrid systems.

@ast

Dynamical modeling of drug effect using hybrid systems.

@en

prefLabel

Dynamical modeling of drug effect using hybrid systems.

@ast

Dynamical modeling of drug effect using hybrid systems.

@en

P1476

Dynamical modeling of drug effect using hybrid systems.

@en

P2093

Lijun Qian

http://www.w3.org/2001/XMLSchema#string

Xiangfang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.

Pharmacokinetic-pharmacodynamic modeling: why?

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Assessing the efficacy of molecularly targeted agents on cell line-based platforms by using system identification.

Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.

Modeling and simulation of genetic regulatory systems: a literature review.

Rational drug discovery: what can we learn from regulatory networks?

P2888

1687-4153-2012-19

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1687-4153-2012-19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Edward R. Dougherty

P577

2012-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233994493

http://www.w3.org/2001/XMLSchema#string

P6179

1022352278

http://www.w3.org/2001/XMLSchema#string

P698

23268741

http://www.w3.org/2001/XMLSchema#string

P932

3639233

http://www.w3.org/2001/XMLSchema#string

Dynamical modeling of drug effect using hybrid systems.

about

P2860

P2860

Dynamical modeling of drug effect using hybrid systems.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932